About Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US, Inc. is a diversified holding company headquartered in Matawan, New Jersey. Originally founded as a pure-play biotechnology firm, the company’s core medical operations focus on the clinical development and regulatory approval of proprietary, non-opioid, biologic-based therapies for chronic pain management, including its lead Phase III candidate for knee osteoarthritis.






